A clinical study to study the social awareness and Clinical Profiles of Patients With Irritable Bowel Syndrome (Gastric Disease) in India

A Cross-sectional, Multicenter, Epidemiological Study to Determine the Sociodemographic and Clinical Profiles of Patients With Irritable Bowel Syndrome (IBS) in India

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/07/020067

Enrollment

300

Registered

2019-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K589- Irritable bowel syndrome without diarrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male or female patients aged >= 18 years 2. Patients diagnosed with IBS in last 1 month as per the Asian criteria 3. Patients who are willing to participate in the study and competent to sign a patient authorization form (PAF) for participation in the registry

Exclusion criteria

Exclusion criteria: 1. IBS patients with evidence of structural abnormality in the GI tract or diseases/conditions that may affect bowel transit 2. IBS patients with evidence of acute GI conditions like obstructions, bleeding, and perforation, or GI surgery 3. IBS patients with evidence of severe systemic disorders (cardiac, hepatic, neurological, or renal) 4. Pregnant or lactating patients 5. Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion in the study

Design outcomes

Primary

Measure	Time frame
Sociodemographic profile of patients with IBS: Number and percentage of patients with following characteristicsTimepoint: Sociodemographic profile of patients with IBS: Number and percentage of patients with following characteristics	—

Secondary

Measure	Time frame
1.Symptom burden 2.Diagnostic and management practices for IBS 3.Impact of IBS on QoLTimepoint: 1.Mean Gastrointestinal Symptom Rating Scale- Irritable Bowel Syndrome (GSRS-IBS) score 2.Number and percentage of patients advised additional investigations like colonoscopy, fecal calprotectin, blood count, stool test, etc 3.Mean score of IBS-36 QoL scale	—

Countries

India

Contacts

Public ContactMr Satish Marukruti

F.S Endocrine & Diabetic Centre

abdulkhaliq_23@yahoo.com9885035977

Outcome results